Matthew Hendrich, MD
Vascular Surgery · Jonesboro, ARNPI 1528220639
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Silk Road Medical, Inc. at 51.9% of the total. 2025 is the largest year on record at $10,970, 4.9 times the $2,247 reported in 2019.
Across 193 payments — averaging $211.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$21K
- Endologix LLC$8K
- Boston Scientific$8K
- W. L. Gore & Associates, Inc.$989
- Cvrx, Inc.$449
- Haemonetics Corporation$252
- plus $1K from 18 others
What the payments were for
- Consulting fees$12,25030%
- Speaking & faculty fees$11,65029%
- Travel & lodging$2,3446%
- Food & beverage$14,54336%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 47 | $21,152 |
| Endologix LLC | 30 | $8,432 |
| Boston Scientific | 29 | $8,225 |
| W. L. Gore & Associates, Inc. | 33 | $989 |
| Cvrx, Inc. | 8 | $449 |
| Haemonetics Corporation | 2 | $252 |
| Abbott | 6 | $244 |
| Medtronic(2 entities) | 8 | $196 |
| Cook Medical LLC | 5 | $171 |
| Stryker | 4 | $115 |
| EKOS Corporation | 3 | $87 |
| Baxter Healthcare | 1 | $80 |
| Getinge USA Sales, LLC | 3 | $77 |
| Lemaitre Vascular, Inc. | 3 | $70 |
| Angiodynamics, Inc. | 2 | $68 |
| Edwards Lifesciences | 1 | $33 |
| Johnson & Johnson | 1 | $25 |
| Abiomed | 1 | $20 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Surmodics, Inc. | 1 | $20 |
| Merck | 1 | $17 |
| Inari Medical, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Irhythm Technologies, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$33,376
- ENROUTE Transcarotid Stent$20,610
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$7,416
- Alto Abdominal Stent Graft System$3,388
- Ovation$2,601
- GENERAL - THERAPIES$1,952
- AFX$1,833
- Torus Stent Graft System$1,093
- ENDOCROSS Device$1,093
- AFX2 Bifurcated Endograft System$489
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$317
- GENERAL VASCULAR INTERVENTION$257
- TEG6s HEMOSTASIS SYSTEM$252
- Ovation iX Iliac Stent Graft$182
- Barostim Neo System$176
- ALTO$156
- ESPRIT$136
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$135
- EMBOLD Fibered$120
How this compares
Too few vascular surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $65,119 |
| BrilintaTicagrelor | 68 | $33,538 |
| XareltoRivaroxaban | 22 | $14,284 |
| ClopidogrelClopidogrel Bisulfate | 644 | $4,330 |
| Atorvastatin Calcium | 127 | $663 |
| Cilostazol | 33 | $443 |
| Amlodipine Besylate | 44 | $324 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $271 |
| Lisinopril | 29 | $141 |
| Mupirocin | 16 | $119 |
| Clonidine Hcl | 31 | $107 |
| Pantoprazole Sodium | 20 | $76 |
| Cephalexin | 22 | $70 |
| Gabapentin | 19 | $56 |
| Metoprolol Tartrate | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $25 | $14,28422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular surgery providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other vascular surgery in Jonesboro
- Mark WrightJonesboro$28K
- Jack HavdalaJonesboro$6K
- Daniel StevensonJonesboro$885
- Christopher StoutRogers$333K
- Mohammed MoursiLittle Rock$116K
- Nestor AritaMountain Home$19K
- Heather LeblancPine Bluff$16K
- Kalenda KasanganaLittle Rock$15K
- Kyla Shelton LangLittle Rock$14K
- Andre RamdonLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.